Open AccessIntrahepatic Viral Kinetics During Direct-Acting Antivirals for Hepatitis C in Human Immunodeficiency Virus Coinfection: The AIDS Clinical Trials Group A5335S Substudy
Author(s) -
Ashwin Balagopal,
Laura Smeaton,
Jeffrey Quinn,
Charles Venuto,
Gene D. Morse,
Vincent Vu,
Beverly Alston-Smith,
Daniel E. Cohen,
Jorge SantanaBagur,
Donald D. Anthony,
Mark S. Sulkowski,
David L. Wyles,
Andrew H. Talal
Publication year - 2020
Publication title -
the journal of infectious diseases (online. university of chicago press)/the journal of infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.69
H-Index - 252
eISSN - 1537-6613
pISSN - 0022-1899
DOI - 10.1093/infdis/jiaa126
Subject(s) - ombitasvir , dasabuvir , paritaprevir , hepatitis c virus , coinfection , medicine , ritonavir , hepatitis c , virology , liver biopsy , ribavirin , viral load , hepacivirus , immunology , gastroenterology , virus , biopsy , antiretroviral therapy
Direct-acting antivirals (DAAs) targeting hepatitis C virus (HCV) have revolutionized outcomes in human immunodeficiency virus (HIV) coinfection.